Sanofi (SNY) and the US buyout firm are set to announce exclusivity as early as Monday, they said. State-owned investment firm Bpifrance is set to take a minority interest in the OTC unit as part ...

Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite the commitments it faces in France, CD&R has been drawn to the Sanofi ...

Sanofi had rights to the OTC version of the drug that was recalled in 2019 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA), with the FDA banning sales the ...

Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.

The cough and cold relief drugs brand from Procter and Gamble topped the list of Rx and OTC pharma brands by impressions ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy. The ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

(Bloomberg) -- After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over-the-counter business to a US buyout firm descended into ...

Sanofi and CD&R enter exclusive talks to sell ... Opella is the third-largest business worldwide in the over-the-counter and vitamins, minerals & supplements market (OTC & VMS), serving over ...

(Bloomberg) — Sanofi entered a fresh round of exclusive negotiations to sell control of its consumer health unit to Clayton Dubilier & Rice after France secured commitments on local employment and ...